Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Inventory (2016 - 2025)

CV Sciences (CVSI) has disclosed Inventory for 13 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Inventory fell 16.54% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, down 16.54% year-over-year, with the annual reading at $4.1 million for FY2025, 16.54% down from the prior year.
  • Inventory hit $4.1 million in Q4 2025 for CV Sciences, roughly flat from $4.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $9.2 million in Q2 2021 to a low of $4.1 million in Q3 2025.
  • Historically, Inventory has averaged $6.3 million across 5 years, with a median of $5.8 million in 2023.
  • Biggest five-year swings in Inventory: rose 9.0% in 2021 and later fell 24.11% in 2025.
  • Year by year, Inventory stood at $8.6 million in 2021, then fell by 23.9% to $6.6 million in 2022, then fell by 13.84% to $5.7 million in 2023, then dropped by 13.4% to $4.9 million in 2024, then decreased by 16.54% to $4.1 million in 2025.
  • Business Quant data shows Inventory for CVSI at $4.1 million in Q4 2025, $4.1 million in Q3 2025, and $4.2 million in Q2 2025.